Table 3.
Secondary outcome (pressure sores and superinfections).
| Pressure Sores |
Superinfections |
|||||
|---|---|---|---|---|---|---|
| Present | Absent | P | Present | Absent | p | |
| N | 26 | 489 | 109 | 406 | ||
| Sex (M) | 19 (73.1%) | 334 (68.3%) | 0.672 | 78 (71.6%) | 275 (67.7%) | 0.445 |
| Age (years) | 71.9 ± 13.7 | 64.7 ± 14.2 | 0.009 | 63.0 ± 14.7 | 65.6 ± 14.1 | 0.131 |
| BMI | 26.6 ± 4.2 | 27.4 ± 5.6 | 0.735 | 27.9 ± 5.9 | 27.2 ± 5.4 | 0.329 |
| Fasting | 5 (19.2%) | 67 (13.7%) | 0.390 | 20 (18.4%) | 52 (12.8%) | 0.161 |
| Ongoing enteral nutrition | 0 | 16 (3.3%) | 1.000 | 8 (7.3%) | 8 (2.0%) | 0.009 |
| Oxygen Therapy | 20 (76.9%) | 263 (53.8%) | 0.025 | 69 (63.3%) | 214 (52.7%) | 0.048 |
| Intubation at T0 | 0 | 10 (2.0%) | 1.000 | 5 (4.6%) | 5 (1.2%) | 0.040 |
| Dysphagia | 2 (7.7%) | 13 (2.7%) | 0.172 | 6 (5.5%) | 9 (2.2%) | 0.101 |
| Arterial hypertension in therapy | 17 (65.4%) | 231 (47.2%) | 0.106 | 55 (50.5%) | 193 (47.5%) | 0.588 |
| Current neoplasia | 0 | 41 (8.4%) | 0.253 | 10 (9.2%) | 31 (7.6%) | 0.556 |
| MUST | 0.34 ± 0.77 | 0.50 ± 0.86 | 0.243 | 0.41 ± 0.92 | 0.33 ± 0.74 | 0.621 |
| Oxygen Therapy | 24 (92.3%) | 351 (71.8%) | 0.022 | 89 (81.7%) | 286 (70.4%) | 0.020 |
| NIV-Cpap | 8 (30.8%) | 84 (17.2%) | 0.109 | 36 (33.0%) | 56 (13.8%) | <0.001 |
| Hospitalisation days | 19.5 (16–47) | 13 (2–66) | 0.022 | 17 (2–66) | 10.5 (2–36) | 0.009 |
| Hospitalisation length | 36 (6–74) | 11 (2–91) | <0.001 | 19 (2–80) | 10 (2–91) | <0.001 |